Commentary · 28 Apr 2022
Review articlePublished 31 Jan 2022
Blood Neurofilament Light Chain Measurement Toward Clinical Application .
1Department of Mental Health Promotion, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; 2Health and Counseling Center, Osaka University, Toyonaka, Osaka, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biomarkers are necessary for the evaluation of disease activity and treatment effects in neurological diseases. However, current tests such as cerebrospinal fluid analysis or imaging cannot be used widely because of several limitations, such as high invasiveness, high costs, and a limited number of tests per day. The blood neurofilament light chain (NFL) assay is a promising test for neuronal injury with low invasiveness and high scalability and has attracted a great deal of attention. It became more precise and accurate because of the newly developed ultrasensitive immunoassay called the Simoa assay. Blood NFL assay could reportedly track disease activity, monitor treatment response, and predict clinical outcomes in various neurological diseases such as multiple sclerosis, amyotrophic lateral sclerosis, dementia, stroke, and traumatic brain injury. In this review, we describe the scope and limitations of blood NFL assay in neurological diseases and future research directions needed for clinical application.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 23 Dec 2020
Blood neurofilament light concentration
Research article · 2017
Multiple Sclerosis: Neurofilament Pathology in Spinal Motor Neurons
Research article · 29 Mar 2013
Characterization of antibody titer and immunogenic feature of light chain of botulinum neurotoxin type A
Research article · 2 Aug 2021
Plasma Neurofilament Light Combined with Risk Genes for the Diagnosis of Alzheimer's Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Neuroimmunology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Shoshin Akamine”
- BylineArticles whose byline prints “Takashi Kudo”